The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for trofolastat (RoTecPSMA), a ...

UK's King's College London has spearheaded a trial that demonstrates AI can minimise the time required for 20-week pregnancy ...

Mainz Biomed has enrolled the first subject in its eAArly DETECT 2 feasibility study, aimed at evaluating colorectal cancer ...

Swedish company Sigrid’s weight loss product Carb Fence has been recognised by the US Food and Drug Administration as a ...

Pantheon Vision has signed a deal with Eyedeal Medical to advance the manufacturing of its corneal implants for treating ...

TOOsonix has formed a strategic collaboration with Consultronix to introduce its “focused” ultrasound skin therapy in Poland.

Though late to the party compared to other industry mammoths, Abbott joins a pulsed field ablation market poised for ...

INBS has secured a US patent for the Intelligent Fingerprinting Drug Screening Cartridge, reinforcing drug screening ...

The automated system, which helps cancer detection in dense breast tissue, can advance breast cancer screening pathways.

AI can be used to help improve both disease diagnosis and treatment plans, leading to better patient outcomes.

Splash Clinical and C2N Diagnostics have collaborated to enhance the recruitment process for clinical trials of Alzheimer's ...

Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the ...